Literature DB >> 21196051

Remission after first-episode schizophrenia: results of a long-term follow-up.

Alp Üçok1, Serap Serbest, Pınar Elif Kandemir.   

Abstract

The aim of this study was to identify the rate and predictors of remission after first episode of schizophrenia (FES). Ninety-three FES patients were followed for at least 12 months and up to 12 years (mean=58.4 months) including monthly assessments with the Brief Psychiatric Rating Scale-Expanded (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS), and Scale for the Assessment of Negative Symptoms (SANS). We also administered the Premorbid Adjustment Scale (PAS). We used the remission criteria recently defined by Andreasen et al. (2005). Fifty-six (59.5%) patients met the remission criteria in the first 24 months of the follow-up period, but 40 (71.5%) of these patients could not maintain their status. However, 23 (57%) of these patients later met the remission criteria again. The remission group patients achieved a higher rate of employment both in the first year and overall. In the logistic regression analysis, lower negative and higher positive symptoms at admission, lower positive symptoms at month 3 of the follow-up, medication compliance in the first 6 months, and occupational status during the last month before admission were found related to remission status. Our findings suggest that the remission group has advantages in terms of occupational status and symptom severity compared with their counterparts who did not achieve or maintain a state of remission.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196051     DOI: 10.1016/j.psychres.2010.11.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.

Authors:  Alp Üçok; Ugur Çıkrıkçılı; Ceylan Ergül; Öznur Tabak; Ada Salaj; Sercan Karabulut; Christoph U Correll
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 2.  Functional outcomes in schizophrenia: employment status as a metric of treatment outcome.

Authors:  Rebecca Schennach; Richard Musil; Hans-Jürgen Möller; Michael Riedel
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

3.  A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery.

Authors:  Herbert Y Meltzer; Min Young Sim; Adam Anderson; Christopher Cannistraci; Karu Jayathilake; Daniel Barrett Share; Myung Lee
Journal:  CNS Neurosci Ther       Date:  2018-07       Impact factor: 5.243

Review 4.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

5.  Neurological soft signs in early stage of schizophrenia associated with obsessive-compulsive disorder.

Authors:  B E Focseneanu; I Dobrescu; G Marian; V Rusanu
Journal:  J Med Life       Date:  2015

Review 6.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Authors:  Maren Carbon; Christoph U Correll
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

7.  Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme.

Authors:  Olesya Ajnakina; Craig Morgan; Charlotte Gayer-Anderson; Sherifat Oduola; François Bourque; Sally Bramley; Jessica Williamson; James H MacCabe; Paola Dazzan; Robin M Murray; Anthony S David
Journal:  BMC Psychiatry       Date:  2017-08-25       Impact factor: 3.630

8.  Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study.

Authors:  Olesya Ajnakina; John Lally; Marta Di Forti; Anna Kolliakou; Poonam Gardner-Sood; Javier Lopez-Morinigo; Paola Dazzan; Carmine M Pariante; Valeria Mondelli; James MacCabe; Anthony S David; Fiona Gaughran; Robin M Murray; Evangelos Vassos
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-07-05       Impact factor: 4.328

9.  Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.

Authors:  Rashmi Patel; Nishamali Jayatilleke; Matthew Broadbent; Chin-Kuo Chang; Nadia Foskett; Genevieve Gorrell; Richard D Hayes; Richard Jackson; Caroline Johnston; Hitesh Shetty; Angus Roberts; Philip McGuire; Robert Stewart
Journal:  BMJ Open       Date:  2015-09-07       Impact factor: 2.692

10.  Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.

Authors:  Tak Lam Lo; Matthew Warden; Yanling He; Tianmei Si; Seshadri Kalyanasundaram; Manickam Thirunavukarasu; Nurmiati Amir; Ahmad Hatim; Tomas Bautista; Cheng Lee; Robin Emsley; Jose Olivares; Yen Kuang Yang; Ronnachai Kongsakon; David Castle
Journal:  Asia Pac Psychiatry       Date:  2016-06       Impact factor: 2.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.